glp 1 agonists microdose Microdosing GLP-1 Drugs: What To Know Microdosing GLP-1 for Weight Loss
Description
In Phase 1 and 2a clinical trials, once-daily subcutaneous injections of RG7697 (0.252.5 mg) for 14 days in 56 patients with T2DM and 1.8 mg of RG7697 for 12 weeks in patients with T2DM who were poorly responsive to metformin reduced body weight and improved glycemic control
Both Basaglar and Ozempic can lead to hypoglycemia but the risk is generally much lower with Ozempic
In fact, most reports show a reduction in rates, but I would never argue with someone who says we need to learn more
Drugs which increase GLP-1 levels are associated with a decreased prevalence of Parkinsons disease
